CAS 1126084-37-4

ASP-9521

Description:

ASP-9521, identified by its CAS number 1126084-37-4, is a chemical compound that has garnered attention in pharmaceutical research, particularly in the context of its potential therapeutic applications. While specific characteristics such as molecular weight, structure, and solubility may vary, compounds in this category typically exhibit properties that make them suitable for biological activity. ASP-9521 is often studied for its mechanism of action, which may involve interactions with specific biological targets, potentially influencing pathways related to disease processes. Its efficacy, safety profile, and pharmacokinetics are critical areas of investigation in preclinical and clinical studies. Additionally, the compound's stability, reactivity, and formulation considerations are essential for its development as a therapeutic agent. As research progresses, more detailed information regarding its characteristics and applications will become available, contributing to a better understanding of its role in medicinal chemistry.

ASP-9521

CAS: 1126084-37-4

Formula: C₁₉H₂₆N₂O₃

Purity: 98%

Color and Shape: Solid

Molecular weight: 330.4213

Ref: IN-DA0092VM

(4-(2-Hydroxy-2-Methylpropyl)Piperidin-1-Yl)(5-Methoxy-1H-Indol-2-Yl)Methanone

CAS: 1126084-37-4

(4-(2-Hydroxy-2-Methylpropyl)Piperidin-1-Yl)(5-Methoxy-1H-Indol-2-Yl)Methanone

Purity: 98%

Molecular weight: 330.42g/mol

Ref: 54-OR1022915

ASP-9521

CAS: 1126084-37-4

ASP-9521

Purity: ≥95%

Molecular weight: 330.42g/mol

Ref: 54-BUP13700

ASP-9521

CAS: 1126084-37-4

ASP-9521 is a selective, potent and orally active indole-based AKR1C3 inhibitor with an IC50 of 11 nM for human AKR1C3.Cost-effective and quality-assured.

Formula: C₁₉H₂₆N₂O₃

Purity: 95.11% - 96.96%

Color and Shape: Solid

Molecular weight: 330.42

Ref: TM-T4529

ASP 9521

CAS: 1126084-37-4

ASP 9521 is a potent, orally available inhibitor of the human androgen receptor. ASP 9521 is a non-steroidal, antiandrogen drug that binds to the androgen receptor with high affinity (Ki=5 nM) and selectivity. The compound has been shown to inhibit prostate cancer cell growth in vitro and in vivo. This agent has been shown to be well tolerated in animals at doses up to 200 mg/kg/day for 14 days, with no evidence of toxicity or adverse effects.

Formula: C₁₉H₂₆N₂O₃

Purity: Min. 95%

Molecular weight: 330.42 g/mol

Ref: 3D-BVB08437